Does next-generation sequencing of cyst fluid improve management of pancreatic cystic neoplasms?
Research output: Contribution to journal › Review article
Pancreatic cystic lesions represent a heterogeneous group of diseases ranging from benign to malignant lesions. They are increasingly being detected due to the widespread use of cross-sectional imaging. Their management is a challenge because it is often not possible to reliably discriminate between malignant and nonmalignant lesions using current imaging technology. Next-generation sequencing (NGS) has the ability of both whole genome and targeted sequencing at a low cost and from a limited amount of DNA. NGS of cyst fluid aspired by endoscopic ultrasonography-guided fine-needle aspiration provides a valuable tool in biomarker research and may in the future help improve diagnosis and management of pancreatic cystic lesions.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Number of pages||3|
|Journal||Scandinavian Journal of Gastroenterology|
|Publication status||Published - 2017 Oct 3|